Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment

Editorial: Hybrid or mixed myelodyplastic/myeloproliferative disorders: Current trends in diagnosis and treatment

Bibliographic Details
Main Authors:	Argiris Symeonidis, Ulrich Germing
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Oncology
Subjects:	mixed MDS/MPN chronic myelomonocytic leukemia (CCML) atypical chronic myeloid leukemia (aCML) myelodyslastic/myeloproliferative neoplasms (MDS/MPN) WHO classification - myeloid neoplasms - diagnostic criteria
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1166163/full

Similar Items

Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders – Epidemiological Features and Overview
by: Andrea Kuendgen, et al.
Published: (2021-11-01)

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
by: Margo B. Gerke, et al.
Published: (2023-07-01)

Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review
by: Diletta Fontana, et al.
Published: (2023-06-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Clinical management of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes
by: Joseph A. Clara, et al.
Published: (2016-09-01)

The importance of evaluating specific myeloid malignancies in epidemiological studies of environmental carcinogens
by: K. A. Mundt, et al.
Published: (2021-03-01)

Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
by: Theodoros Karantanos, et al.
Published: (2021-03-01)

Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review
by: Enrico Barozzi, et al.
Published: (2022-01-01)

Iron Chelation in Patients with Myelodysplastic Syndromes and Myeloproliferative Neoplasms—Real-World Data from the German Noninterventional Study EXCALIBUR
by: Felicitas Schulz, et al.
Published: (2023-10-01)

The Classification of Myeloproliferative Neoplasms: Rationale, Historical Background and Future Perspectives with Focus on Unclassifiable Cases
by: Marco Pizzi, et al.
Published: (2021-11-01)

Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders
by: Argiris Symeonidis, et al.
Published: (2022-08-01)

Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment
by: Alessia Castellino, et al.
Published: (2021-10-01)

MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES
by: I. N. Subortseva, et al.
Published: (2017-01-01)

An unusual response to 5‐azacitidine by a patient with chronic myelomonocytic leukemia
by: Anwarul Islam
Published: (2023-08-01)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
by: Diletta Fontana, et al.
Published: (2021-11-01)

Chronic Myelomonocytic Leukemia: Hematopathology Perspective
by: Siba El Hussein, et al.
Published: (2021-08-01)

Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)
by: Lina Hollenbach, et al.
Published: (2024-02-01)

What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias
by: Marco Pizzi, et al.
Published: (2023-03-01)

Examining disease boundaries: Genetics of myelodysplastic/myeloproliferative neoplasms
by: Michael J. Hochman, et al.
Published: (2021-08-01)

Clinical characteristics and symptom burden of Thai myeloproliferative neoplasm patients
by: Naritsara Cherdchoo, et al.
Published: (2023-12-01)

Case report of an enigmatic childhood hematomalignancy
by: M Geetha, et al.
Published: (2019-01-01)

Leucemia mielomonocítica crónica
by: Yamilé Quintero-Sierra, et al.

EZH2 in Myeloid Malignancies
by: Jenny Rinke, et al.
Published: (2020-07-01)

Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype
by: Sonja Heibl, et al.
Published: (2020-07-01)

Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape
by: Muftah Mahmud, et al.
Published: (2023-12-01)

Chronic Myelomonocytic Leukemia Gold Jubilee
by: Eric Solary, et al.
Published: (2021-07-01)

Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen
by: Nikeeta Mandhan, et al.
Published: (2022-01-01)

Screening for an underlying myeloproliferative neoplasm in patients with thrombocytosis post-induction chemotherapy for acute myeloid leukemia
by: Stephen E. Langabeer
Published: (2020-01-01)

Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
by: Yammy Yung, et al.
Published: (2021-01-01)

Editorial: Novel Treatment Strategies for Myeloproliferative Neoplasms
by: Ken-Hong Lim, et al.
Published: (2021-09-01)

CSF3R T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profile
by: Adelaide Kwon, et al.
Published: (2022-01-01)

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
by: Jan Philipp Bewersdorf, et al.
Published: (2021-03-01)

A case series of clinical and hematological profile of juvenile myelomonocytic leukemia
by: Anurag Saha, et al.
Published: (2022-12-01)

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry
by: Judith Gecht, et al.
Published: (2021-08-01)

Novel Therapies in Myeloproliferative Neoplasms: Beyond JAK Inhibitor Monotherapy
by: Sophia S. Lee, et al.
Published: (2021-08-01)

Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
by: Arti Easwar, et al.
Published: (2021-10-01)

Disabled, invisible and dismissed—The lived experience of fatigue in people with myeloproliferative neoplasms
by: Ashleigh Bradford, et al.
Published: (2023-01-01)

Non-Classic Myeloproliferative Neoplasms: Are We Really Aware of These Rare Diseases in Daily Practice
by: Serdal Korkmaz
Published: (2017-08-01)

Symptomatic burden amongst myeloproliferative neoplasm patients: mpn-10 prospective assessment in a portuguese cohort
by: Maria Sarmento, et al.
Published: (2021-12-01)

Recurrent bilateral adrenal infarction with myelodysplastic/myeloproliferative neoplasm-unclassifiable (MDS/MPN-U): a case report
by: Yoshitomo Hoshino, et al.
Published: (2023-06-01)